In: Other
Use Method of Undetermined Coefficients te find a particular solution of the non-homogeneous equation. Find general solution of the non-homogeneous equation.
y''+2y'+5y=3sin(2t)
In: Advanced Math
Use Method of Undetermined Coefficients te find a particular solution of the non-homogeneous equation. Find general solution of the non-homogeneous equation.
y''+2y'+y=2e^t
In: Advanced Math
Use Method of Undetermined Coefficients te find a particular solution of the non-homogeneous equation. Find general solution of the non-homogeneous equation.
y''+2y'+y=2e^{-t}
In: Computer Science
Compare and contrast a crafts fair and farmers market to a non-standardized market where consumers do not perceive sellers as all being the same.
Provide an example of a non-standardized market.
In: Economics
Tax Credits
In: Accounting
Java:
Find a pattern that will match any string that is
-- at least 6 characters long,
-- and begins with a letter or number (\w)
-- and contains at least one non-letter and non-number (\W).
In: Computer Science
. Differentiate between metric and non-metric scale of measurement by giving suitable examples. Give examples of statistical tools where the two types of data (metric and non-metric) are used.
In: Operations Management
Dividend splitting between Preferred and Common Shares
C/S 1,000,000 shares of $2 par; APIC- C/S = $20,000,000
P/S 100,000 shares of 5%, $30 par; APIC- P/S = $5,000,000
R/E (Yr 1) = $1,600,000
R/E (Yr 2) = $1,800,000
Dividends paid for Yr 1 are $ - 0 - and dividends for Yr 2 are $ 800,000.
Determine the proper split of dividends for YR 1 and YR 2 if:
a. P/S is non-cumulative and non-participating
b. P/S is cumulative and non-participating
c. P/S is non-cumulative and participating
d. P/S is cumulative and participating
In: Accounting
Please summarize the abstract of the article below. Article name is Diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. What i dont understand is in bold.
Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the diference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 has not been analyzed. Coagulation results and clinical features of consecutive patients with severe pneumonia induced by SARS-CoV2 (COVID group) and non-SARS-CoV2 (non-COVID group) in Tongji hospital were retrospectively analyzed and compared. Whether patients with elevated D-dimer could beneft from anticoagulant treatment was evaluated. There were 449 COVID patients and 104 non-COVID patients enrolled into the study. The 28-day mortality in COVID group was approximately twofold of mortality in non-COVID group (29.8% vs. 15.4%, P=0.003), COVID group were older (65.1±12.0 vs. 58.4±18.0, years, P<0.001) and with higher platelet count (215±100 vs. 188±98, ×109/L, P=0.015), comparing to non-COVID group. The 28-day mortality of heparin users were lower than nonusers In COVID group with D-dimer>3.0 μg/mL (32.8% vs. 52.4%, P=0.017).Patients with severe pneumonia induced by SARS-CoV2 had higher platelet count than those induced by non-SARS-CoV2, and only the former with markedly elevated D-dimer may beneft from anticoagulant treatment.
In: Biology